Cargando…
Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization
The wet type of age-related macular degeneration (AMD) accompanies the subfoveal choroidal neovascularization (CNV) caused by the abnormal extension or remodeling of blood vessels to the macula and retinal pigment epithelium (RPE). Vascular endothelial growth factor (VEGF) is known to play a crucial...
Autores principales: | Kim, E Seul, Lee, Min Sang, Jeong, Hayoung, Lim, Su Yeon, Kim, Doha, Kim, Dahwun, Jung, Jaeback, Lyu, Siyan, Cho, Hee Joo, Kim, Dong Min, Suh, Wonhee, Jeong, Ji Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538988/ https://www.ncbi.nlm.nih.gov/pubmed/34683841 http://dx.doi.org/10.3390/pharmaceutics13101548 |
Ejemplares similares
-
Comparison of the Therapeutic Efficacies of Topical Rivoceranib and Topical Bevacizumab in a Murine Model of Corneal Neovascularization
por: Yoon, Hyeon Jeong, et al.
Publicado: (2019) -
Enhanced Transfection of Human Mesenchymal Stem Cells Using a Hyaluronic Acid/Calcium Phosphate Hybrid Gene Delivery System
por: Lee, Jung Eun, et al.
Publicado: (2019) -
Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks
por: Esen, Ebru, et al.
Publicado: (2015) -
Intravitreal Ranibizumab for Subfoveal Choroidal Neovascularization from Age-Related Macular Degeneration with Combined Severe Diabetic Retinopathy
por: Han, So Young, et al.
Publicado: (2015) -
Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
por: Mandal, Subrata, et al.
Publicado: (2011)